US2008286817A1PendingUtilityA1

Novel allergens and treatment

Assignee: OVITA LTDPriority: Apr 19, 2000Filed: Nov 9, 2007Published: Nov 20, 2008
Est. expiryApr 19, 2020(expired)· nominal 20-yr term from priority
C07K 14/43563A61P 33/14A61P 37/08A61K 39/00
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention is related to novel nucleotide sequences encoding a louse allergen and a methods for diagnosing, treating and preventing lice infestation and associated allergic disease with the nucleotide sequences and protein allergen of the invention. The present invention also relates to kits for diagnostic assays.

Claims

exact text as granted — not AI-modified
1 . A method of diagnosing an ectoparasite infestation in a host organism, comprising:
 obtaining an excretion, secretion, tissue or blood sample from the host organism; and   identifying the presence of an antigen present in the ectoparasite's feces in said sample, wherein the presence of said antigen indicates the presence of said infestation.   
     
     
         2 . The method of  claim 1 , wherein the identifying step comprises an ELISA assay.

Join the waitlist — get patent alerts

Track US2008286817A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.